Clinical Trial

A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

Name: A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer — clinical trial record (NCT07641855)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This study will first conduct a phase II clinical study, and on the basis of the phase II clinical study, subsequent clinical research will be carried out.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-08.

Trial Details

NCT Number	NCT07641855
Lead Sponsor	Sichuan Baili Pharmaceutical Co., Ltd. Collaborators: Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.
Conditions	Castration-resistant Prostate Cancer
Enrollment	180 participants
Start Date	2026-09
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-23